Pain as Indication for Operative Treatment of Traumatic Rib Fractures
NCT ID: NCT02094807
Last Updated: 2018-07-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2014-04-30
2020-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Opioid-Free Pain Treatment in Trauma Patients
NCT06078371
Bimodal Analgesia as Form of Pain Control Post Long Bone Fracture
NCT00240396
Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients
NCT02432456
Effect of a Multimodal Pain Regimen on Pain Control, Patient Satisfaction and Narcotic Use in Orthopaedic Trauma Patients
NCT02160301
NSAIDS vs Opioids in Tibial Fractures
NCT05332314
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conservative management
Not operated. Thoracic epidural anesthesia will be used togeteher with paracetamol. If not sufficient opioids and NSAID will be added.
NSAID
Will be used if other drugs are not tolerated.
thoracic epidural anesthesia
Continous epidural anesthesia will be introduced by specialists in Anesthesia and Intensive care.
opioids
During firs 24 hours i.v will be used. Then slow releas tabletts will be preferred.
paracetamol
100mg x 4 i.v. during the first 24 hours. Then orally 100mg x 4.
Operative management
Operative fixation of rib fractures. Thoracic epidural anesthesia will be used togeteher with paracetamol. If not sufficient opioids and NSAID will be added.
NSAID
Will be used if other drugs are not tolerated.
thoracic epidural anesthesia
Continous epidural anesthesia will be introduced by specialists in Anesthesia and Intensive care.
opioids
During firs 24 hours i.v will be used. Then slow releas tabletts will be preferred.
paracetamol
100mg x 4 i.v. during the first 24 hours. Then orally 100mg x 4.
operative fixation of rib fractures
Fractures will be stabilized on the outside of of the ribs.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NSAID
Will be used if other drugs are not tolerated.
thoracic epidural anesthesia
Continous epidural anesthesia will be introduced by specialists in Anesthesia and Intensive care.
opioids
During firs 24 hours i.v will be used. Then slow releas tabletts will be preferred.
paracetamol
100mg x 4 i.v. during the first 24 hours. Then orally 100mg x 4.
operative fixation of rib fractures
Fractures will be stabilized on the outside of of the ribs.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. A minimum of 4 rib fractures
2. Pain that requires analgesia in the form of opioids in equivalent doses of \> 25 mg iv morphine daily
Exclusion Criteria
2. Severe head injury where normal level of consciousness is not present
3. Severe neurological and musculoskeletal diseases that influence the function of the thoracic wall and lung volumes
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sahlgrenska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eva-Corina Caragounis
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hans Granhed, MD PhD
Role: STUDY_DIRECTOR
Sahlgrenska University Hospital
Eva-Corina Caragounis, MD
Role: PRINCIPAL_INVESTIGATOR
Sahlgrenska University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sahlgrenska University Hospital
Gothenburg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
epn887-13
Identifier Type: REGISTRY
Identifier Source: secondary_id
hg481115
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.